ArticleBMC veterinary research2026
Isolation and characterization of a lytic bacteriophage against Staphylococcus aureus.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Staphylococcus aureus (S. aureus) is one of major pathogens in animal production. S. aureus-induced mastitis poses a serious threat to animal health and leads to significant economic losses. The objective of this study was to isolate and characterize bacteriophage(s) specific to S. aureus and assess its (their) in vitro antibacterial activity. A strain of S. aureus bacteriophage, designated JXAU-SA-P1, was isolated from sewage in a commercial pig farm. Morphological analysis revealed that JXAU-SA-P1 belongs to the Caudovimetes class. The genome of JXAU-SA-P1 is 134.23 kb in length with a GC content of 29.99%, and no virulence or antibiotic resistance genes were identified. JXAU-SA-P1 exhibited a low optimal multiplicity of infection (0.001), a high burst size (300 PFU/cell), and significant antibacterial activity. The bacteriophage showed stable activity below 50 °C and within a pH range of 2.0–12.0. JXAU-SA-P1 effectively inhibited the growth of S. aureus in milk at both 4 °C and 25 °C. Furthermore, it demonstrated substantial biofilm prevention and removal properties. In conclusion, these findings indicate that JXAU-SA-P1 is a potential antibacterial agent for the control of S. aureus-induced mastitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.